These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 27919779)

  • 1. Funding for tuberculosis research-an urgent crisis of political will, human rights, and global solidarity.
    Frick M
    Int J Infect Dis; 2017 Mar; 56():21-24. PubMed ID: 27919779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Funding shortfalls put target to end TB epidemic by 2035 at risk.
    Cousins S
    BMJ; 2016 Oct; 355():i5779. PubMed ID: 27784717
    [No Abstract]   [Full Text] [Related]  

  • 3. Less research on tuberculosis than HIV and malaria when research agendas are poorly coordinated: a systematic review of research outputs from Cambodia.
    Khan M; James R; Sundaram N; Wu S; Eang MT; Vonthanak S; Coker R
    Int J Infect Dis; 2017 Mar; 56():25-29. PubMed ID: 27979784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges and opportunities for eliminating tuberculosis - leveraging political momentum of the UN high-level meeting on tuberculosis.
    Sakamoto H; Lee S; Ishizuka A; Hinoshita E; Hori H; Ishibashi N; Komada K; Norizuki M; Katsuma Y; Akashi H; Shibuya K
    BMC Public Health; 2019 Jan; 19(1):76. PubMed ID: 30651096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cohort for Tuberculosis Research by the Indo-US Medical Partnership (CTRIUMPH): protocol for a multicentric prospective observational study.
    Gupte A; Padmapriyadarsini C; Mave V; Kadam D; Suryavanshi N; Shivakumar SV; Kohli R; Gupte N; Thiruvengadam K; Kagal A; Meshram S; Bharadwaj R; Khadse S; Ramachandran G; Hanna LE; Pradhan N; Gomathy NS; DeLuca A; Gupta A; Swaminathan S;
    BMJ Open; 2016 Feb; 6(2):e010542. PubMed ID: 26916698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Falling Short of the Rights to Health and Scientific Progress: Inadequate TB Drug Research and Access.
    Frick M; Henry I; Lessem E
    Health Hum Rights; 2016 Jun; 18(1):9-24. PubMed ID: 27780996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plan to combat extensively drug-resistant tuberculosis: recommendations of the Federal Tuberculosis Task Force.
    Centers for Disease Control and Prevention (CDC)
    MMWR Recomm Rep; 2009 Feb; 58(RR-3):1-43. PubMed ID: 19214162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How research can help control tuberculosis.
    Chaisson RE; Harrington M
    World Hosp Health Serv; 2010; 46(1):33-40. PubMed ID: 20614683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Raising awareness of the importance of funding for tuberculosis small-molecule research.
    Riccardi G; Old IG; Ekins S
    Drug Discov Today; 2017 Mar; 22(3):487-491. PubMed ID: 27664546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anatomy of medical research: US and international comparisons.
    Moses H; Matheson DH; Cairns-Smith S; George BP; Palisch C; Dorsey ER
    JAMA; 2015 Jan; 313(2):174-89. PubMed ID: 25585329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A failure in solidarity: Ethical challenges in the development and implementation of new tuberculosis technologies.
    Komparic A; Dawson A; Boulanger RF; Upshur REG; Silva DS
    Bioethics; 2019 Jun; 33(5):557-567. PubMed ID: 30681168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are scientific research outputs aligned with national policy makers' priorities? A case study of tuberculosis in Cambodia.
    Boudarene L; James R; Coker R; Khan MS
    Health Policy Plan; 2017 Oct; 32(suppl_2):i3-i11. PubMed ID: 29028223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shifting from tuberculosis control to elimination: Where are we? What are the variables and limitations? Is it achievable?
    Centis R; D'Ambrosio L; Zumla A; Migliori GB
    Int J Infect Dis; 2017 Mar; 56():30-33. PubMed ID: 27916675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The end TB strategy for India.
    Sachdeva KS; Mase SR
    Indian J Tuberc; 2019 Jan; 66(1):165-166. PubMed ID: 30878062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The making of a public health problem: multi-drug resistant tuberculosis in India.
    Engel NC
    Health Policy Plan; 2013 Jul; 28(4):375-85. PubMed ID: 22865835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bridging the gap: engaging researchers and advocates to build support for TB vaccine research and development.
    Kennell M; Woolley J
    Tuberculosis (Edinb); 2012 Mar; 92 Suppl 1():S30-2. PubMed ID: 22441157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advocacy, partnership and political commitment for TB vaccine research.
    Olesen OF; Chan S; Chappell J; Guo Y; Leite LC
    Tuberculosis (Edinb); 2016 Aug; 99 Suppl 1():S26-9. PubMed ID: 27402313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tuberculosis eradication versus control.
    Schito M; Hanna D; Zumla A
    Int J Infect Dis; 2017 Mar; 56():10-13. PubMed ID: 27872016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The politics of TB: TB control services need tailoring for new arrivals, not vice versa.
    Wang Y; Taegtmeyer M; Squire SB; Theobald SJ
    Chron Respir Dis; 2008; 5(1):49-51. PubMed ID: 18303102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.